The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with allogeneic hematopoietic stem cell transplantation (HSCT) outcomes in patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL) treated with inotuzumab ozogamicin (InO) versus (v) conventional chemotherapy (C).
 
Partow Kebriaei
No Relationships to Disclose
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; ARIAD; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Incyte; Novartis; Pfizer
 
Matthias Stelljes
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Nicola Gökbuget
Honoraria - Amgen; Pfizer
Research Funding - Amgen; Amgen (Inst); Pfizer; Pfizer (Inst)
 
Hagop M. Kantarjian
Research Funding - Amgen; Astex Pharmaceuticals; Bristol-Myers Squibb; Novartis; Pfizer
 
Anjali S. Advani
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Akil Merchant
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Tao Wang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Fausto Rodriguez Loberiza
Employment - Pfizer
Stock and Other Ownership Interests - Novartis; Pfizer
 
Barbara Sleight
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Erik Vandendries
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
David I. Marks
Consulting or Advisory Role - Amgen; Pfizer